9 cancer-related gene sets were demonstrated to be significantly enriched in the high-risk patient group (Nominal p-value < 0.05, FDR <0.25), including mTORC1 signaling, MYC targets v1, MYC targets v2, G2M checkpoint, E2F targets, mitotic spindle, glycolysis, DNA repair, and unfolded protein response (Figure 6). Here, MYC is linked to cancer.